medigraphic.com
ISSN 2007-2783 (Print)
Órgano Oficial del Instituto Científico Pfizer

2016, Number 3

<< Back

Residente 2016; 11 (3)

Hypertriglyceridemic waist phenotype

Mendoza-Vázquez G, Guadiana-Lozano R, Gámez-Nava JI, González-López L, Salazar-Páramo M, Espinoza-Gómez F, Nava-Zavala AH

Language: Spanish
References: 18
Page: 126-130
PDF size: 224.11 Kb.


ABSTRACT

Hypertriglyceridemic waist phenotype has been defined as a combination of two components: increased triglyceride levels alongside a high waist circumference measure. This phenotype refers to a construct created to identify people at risk for cardiovascular or cardio metabolic diseases through their association with risk factors that lead to said diseases. Previous studies have reaffirmed the importance of this construct as a predictor of cardiovascular risk through its association with metabolic abnormalities which include lipid profile alteration, hypertension, diabetes mellitus, insulin resistance, arterial stiffness, metabolic syndrome, among others. Said diseases are well known due to the consequences they bring with them. Hypertriglyceridemic waist phenotype has also been recognized as a tool that supports an easy and inexpensive detection of said diseases.


REFERENCES

  1. Carrasco F, Reyes E, Rimler O, Ríos F. Predictive accuracy of body mass index in estimating body fatness measured by bioelectrical impedance. Arch Latinoam Nutr. 2004; 54 (3): 280-286.

  2. Motamed N, Perumal D, Zamani F, Ashrafi H, Haghjoo M, Saeedian FS et al. Conicity index and waist-to-hip ratio are superior obesity indices in predicting 10-year cardiovascular risk among men and women. Clin Cardiol. 2015; 38 (9): 527-534.

  3. Lemieux I, Poirier P, Bergeron J, Alméras N, Lamarche B, Cantin B et al. Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol. 2007; 23 Suppl B: 23B-31B. Erratum in: Can J Cardiol. 2009; 25 (3): 140.

  4. Millán Núñez-Cortés J, Mantilla-Morató T, Toro R, Millán-Pérez J, Mangas-Rojas A; Comité Científico del Registro de Hipertrigliceridemias de la Sociedad Española de Arteriosclerosis. Metabolic syndrome in patients with clinical phenotype “hypertriglyceridemic waist”. Nutr Hosp. 2015; 32 (3): 1145-1152.

  5. Díaz-Santana MV, Suárez-Pérez EL, Ortiz-Martínez AP, Guzmán-Serrano M, Pérez-Cardona CM. Association between the hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus among adults in Puerto Rico. J Immigr Minor Health. 2016; 18 (1): 102-109.

  6. Wall-Medrano A, Ramos-Jiménez A, Hernández-Torres RP, Villalobos-Molina R, Tapia-Pancardo DC, Jiménez-Flores JR et al. Cardiometabolic risk in young adults from northern Mexico: Revisiting body mass index and waist-circumference as predictors. BMC Public Health. 2016; 16: 236.

  7. Du T, Sun X, Huo R, Yu X. Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes (Lond). 2014; 38 (6): 840-847.

  8. Cunha de Oliveira C, Carneiro-Roriz AK, Eickemberg M, Barreto-Medeiros JM, Barbosa-Ramos L. Hypertriglyceridemic waist phenotype: association with metabolic disorders and visceral fat in adults. Nutr Hosp. 2014; 30 (1): 25-31.

  9. Blackburn P, Lamarche B, Couillard C, Pascot A, Bergeron N, Prud’homme D et al. Postprandial hyperlipidemia: another correlate of the “hypertriglyceridemic waist” phenotype in men. Atherosclerosis. 2003; 171 (2): 327-336.

  10. Mamtani M, Kulkarni H, Dyer TD, Göring HH, Neary JL, Cole SA et al. Genome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families. Clin Epigenetics. 2016; 8: 6.

  11. Guattini VL, Piovesan CH, Wittke E, Marcadenti A. Hypertriglyceridemic waist (EWET), glycidic and lipid profile in patients with newly diagnosed heart attack. Nutr Hosp. 2015; 32 (3): 1004-1008.

  12. Cabral-Rocha AL, Feliciano-Pereira P, Cristine-Pessoa M, Gonçalves-Alfenas RC, Segheto W, da Silva DC et al. Hypertriglyceridemic waist phenotype and cardiometabolic alterations in Brazilian adults. Nutr Hosp. 2015; 32 (3): 1099-1106.

  13. Gasevic D, Carlsson AC, Lesser IA, Mancini GJ, Lear SA. The association between “hypertriglyceridemic waist” and sub-clinical atherosclerosis in a multiethnic population: a cross-sectional study. Lipids Health Dis. 2014; 13: 38.

  14. Lee BJ, Nam J, Kim JY. Predictors of metabolic abnormalities in phenotypes that combined anthropometric indices and triglycerides. BMC Complement Altern Med. 2016; 16: 59.

  15. Sam S, Haffner S, Davidson MH, D’Agostino RB Sr, Feinstein S, Kondos G et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009; 32 (10): 1916-1920.

  16. Esmaillzadeh A, Azadbakht L. Increased levels of inflammation among women with enlarged waist and elevated triglyceride concentrations. Ann Nutr Metab. 2010; 57 (2): 77-84.

  17. Czernichow S, Bruckert E, Bertrais S, Galan P, Hercberg S, Oppert JM. Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes (Lond). 2007; 31 (5): 791-796.

  18. Gómez-Huelgas R, Bernal-López MR, Villalobos A, Mancera-Romero J, Baca-Osorio AJ, Jansen S et al. Hypertriglyceridemic waist: an alternative to the metabolic syndrome? Results of the IMAP Study (multidisciplinary intervention in primary care). Int J Obes (Lond). 2011; 35 (2): 292-299.




2020     |     www.medigraphic.com